Company Financials

Twist Bioscience Corporation Financials

United States dollar

business Twist Bioscience Corporation Company Profile

Main Stock Listing

NASDAQ: TWST

Market Capitalization $1.98 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE -24.92
Forward PE -13.05
Price to Sales TTM $5.15
Price to Book MRQ $4.07
Enterprise to Revenue 4.77
Enterprise to EBITDA -15.73

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2025-09-30
Most Recent Quarter 2025-09-30
Profit Margin -20.63%
Operating Margin -30.23%
Return on Assets TTM -13.56%
Return on Equity TTM -16.43%

Income Statement

Revenue TTM $376,572,000
Revenue per Share TTM $6.30
Quarterly Revenue Growth 16.90%
Gross Profit TTM $191,002,000
EBITDA $-114,306,000
Net Income to Common TTM $-77,670,000
Diluted EPS TTM $-1.30
Quarterly Earnings Growth YoY 16.88%

Balance Sheet

Total Cash MRQ $232,434,000
Total Cash per Share MRQ $3.80
Total Debt MRQ $
Total Debt to Equity MRQ 19.15
Current Ratio MRQ 3.64
Book Value per Share MRQ $7.80

Cash Flow

Operating Cash Flow TTM $-47,628,000
Levered Free Cash Flow TTM $-32,625,876

TWST Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 60,631,000
Float Shares 55,758,439
Avg 10 Volume 1,076,950
Avg 30 Volume None
Shares Short 13,742,759
Short Ratio 9.03
Short % of Shares 25.32%
% Held by Insiders 2.59%
% Held by Institutions 119.81%

Stock Price Summary

Beta 2.24
Fifty Two Week Low $23.30
Fifty Two Week High $55.33
Fifty Two Week Change -49.77%
Day 50 MA $31.25
Day 200 MA $32.48

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date